» Articles » PMID: 6748160

Intracellular Transport and Secretion of Hepatitis B Surface Antigen in Mammalian Cells

Overview
Journal J Virol
Date 1984 Aug 1
PMID 6748160
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The oligosaccharide processing and secretion of hepatitis B surface antigen (HBsAg) was studied in Chinese hamster ovary cells stably transfected with the gene coding HBsAg. HBsAg was secreted from cells with a relatively long half time (ca. 5 h). This appeared to be a characteristic of HBsAg itself, since HBsAg-producing cells infected with vesicular stomatitis virus transported the viral envelope glycoprotein to the cell surface with normal kinetics (half time of ca. 30 min). The secreted HBsAg was comprised of both the unglycosylated (P20) and the glycosylated (G25) polypeptides, characteristic of HBsAg isolated from human serum or secreted from other cell lines (C. W. Crowley, C.-C. Liu, and A. D. Levinson, Mol. Cell. Biol. 3:44-55, 1983; M. F. Dubois, C. Pourcel, S. Rousset, C. Chang, and P. Tiollais, Proc. Natl. Acad. Sci. U.S.A. 77:4549-4553, 1980; C.-C. Liu, D. Yansura, and A. D. Levinson, DNA, 1:213-221, 1982; G. M. Macnab, J. J. Alexander, G. Lecatsas, E. M. Bey, and J. M. Urbanocvicz, Br. J. Cancer, 24:509-515, 1976; A. M. Moriarity, B. H. Hoyer, J. W.-K. Shih, J. L. Gerin, and D. H. Hamer, Proc. Natl. Acad. Sci. U.S.A. 78:2606-2610, 1981; D. L. Peterson, J. Biol. Chem., 256:6975-6983, 1981). The glycosylated polypeptide (GP25) contained complex oligosaccharide chains. Cell-associated HBsAg also was comprised of both an unglycosylated and a glycosylated polypeptide; however, the glycosylated form (GP23) contained only high-mannose oligosaccharide chains. No oligosaccharide processing of the high-mannose chains could be detected within the cells. Thus, most of the time before secretion of HBsAg from cells must have been spent in a pre-Golgi or early Golgi compartment. Glycosylation was inhibited completely by tunicamycin, although unglycosylated particles were still secreted from cells and were antigenic. The secretion and oligosaccharide processing of HBsAg were inhibited with high concentrations of monensin, but at lower concentrations of monensin HBsAg was still secreted, although only half of the oligosaccharide chains were processed to the complex form.

Citing Articles

Medical Advances in Hepatitis D Therapy: Molecular Targets.

Vogt A, Wohlfart S, Urban S, Mier W Int J Mol Sci. 2022; 23(18).

PMID: 36142728 PMC: 9506394. DOI: 10.3390/ijms231810817.


N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis.

Dobrica M, Lazar C, Branza-Nichita N Cells. 2020; 9(6).

PMID: 32512942 PMC: 7349502. DOI: 10.3390/cells9061404.


Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Ho J, Jeevan-Raj B, Netter H Viruses. 2020; 12(2).

PMID: 31973017 PMC: 7077199. DOI: 10.3390/v12020126.


An E. coli-produced single-chain variable fragment (scFv) targeting hepatitis B virus surface protein potently inhibited virion secretion.

Li C, Wang Y, Liu T, Niklasch M, Qiao K, Durand S Antiviral Res. 2019; 162:118-129.

PMID: 30599174 PMC: 7613426. DOI: 10.1016/j.antiviral.2018.12.019.


Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.

Czarnota A, Tyborowska J, Peszynska-Sularz G, Gromadzka B, Bienkowska-Szewczyk K, Grzyb K Microb Cell Fact. 2016; 15:62.

PMID: 27075377 PMC: 4831159. DOI: 10.1186/s12934-016-0460-4.


References
1.
Almeida J . Electron microscopic observations and speculations on Australia antigen. Postgrad Med J. 1971; 47(549):484-7. PMC: 2467215. DOI: 10.1136/pgmj.47.549.484. View

2.
Lodish H, Kong N, Snider M, Strous G . Hepatoma secretory proteins migrate from rough endoplasmic reticulum to Golgi at characteristic rates. Nature. 1983; 304(5921):80-3. DOI: 10.1038/304080a0. View

3.
DUNN A, Peters R, SCHWEITZER I . An ultrastructural study of liver explants from infants with vertically transmitted hepatitis. Exp Mol Pathol. 1973; 19(1):113-26. DOI: 10.1016/0014-4800(73)90045-2. View

4.
Furuta S, Kiyosawa K, Nagata A, Akahane Y, Oda M . Letter: HBsAg on cell membrane in symptom-free carrier. Lancet. 1975; 2(7927):227. DOI: 10.1016/s0140-6736(75)90693-5. View

5.
Alberti A, Realdi G, Tremolada F, Spina G . Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis. Clin Exp Immunol. 1976; 25(3):396-402. PMC: 1541400. View